| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.1M | -95.1% |
| R&D Expense | $172.9M | +21.9% |
| SG&A Expense | $79.7M | +15.1% |
| Operating Income | -$246.5M | -282.2% |
| Interest Expense | $6.0M | +106.9% |
| Income Tax | $0 | — |
| Net Income | -$250.2M | -281.5% |
| EPS (Basic) | -$2.31 | -220.8% |
| EPS (Diluted) | -$2.31 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $163.0M | -9.4% |
| Short-term Investments | $18.3M | -83.5% |
| Current Assets | $194.8M | -35.9% |
| Total Assets | $348.8M | -1.7% |
| Current Liabilities | $85.6M | +4.1% |
| Long-term Debt | $50.0M | +107.9% |
| Total Liabilities | $338.0M | +51.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$228.8M | -3521.3% |
| Capital Expenditures | $9.8M | +2.7% |
| Investing Cash Flow | $82.4M | +28.6% |
| Financing Cash Flow | $129.6M | — |
| Free Cash Flow | -$238.6M | -8191.8% |
| -220.8% |
| Stockholders' Equity |
| $10.8M |
| -91.8% |